Khaled Alhosaini
- Co-authors
- Othman A. Al‐ShabanahNaif O. Al‐HarbiMohamed M. HafezSheikh F. AhmadMohamed M. Sayed‐AhmedSabry M. AttiaAhmed NadeemHatem M. Abuohashish
- Topics
- Autism Spectrum Disorder Research (5 papers)Drug-Induced Hepatotoxicity and Protection (5 papers)COVID-19 Clinical Research Studies (4 papers)
- Partner nations
- Saudi ArabiaIndiaChina
In The Last Decade
Khaled Alhosaini
43 papers receiving 774 citations
Peers
Comparison fields: 5 of 106
- Molecular Biology 278
- Immunology 130
- Pharmacology 88
- Oncology 85
- Endocrinology, Diabetes and Metabolism 76
Countries citing papers authored by Khaled Alhosaini
This map shows the geographic impact of Khaled Alhosaini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khaled Alhosaini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khaled Alhosaini more than expected).
Fields of papers citing papers by Khaled Alhosaini
This network shows the impact of papers produced by Khaled Alhosaini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khaled Alhosaini. The network helps show where Khaled Alhosaini may publish in the future.
Co-authorship network of co-authors of Khaled Alhosaini
This figure shows the co-authorship network connecting the top 25 collaborators of Khaled Alhosaini. A scholar is included among the top collaborators of Khaled Alhosaini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Khaled Alhosaini. Khaled Alhosaini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 4 | |
| 4 | 26 | |
| 5 | 5 | |
| 6 | 4 | |
| 7 | 3 | |
| 8 | 9 | |
| 9 | 26 | |
| 10 | 18 | |
| 11 | 45 | |
| 12 | 25 | |
| 13 | 6 | |
| 14 | 45 | |
| 15 | 77 | |
| 16 | 9 | |
| 17 | 98 | |
| 18 | 26 | |
| 19 | 17 | |
| 20 | 24 |
About Khaled Alhosaini
Khaled Alhosaini is a scholar working on Pharmacology, Cancer Research and Biological Psychiatry, having authored 44 papers that have together received 794 indexed citations. Recurring topics across this work include Autism Spectrum Disorder Research (5 papers), Drug-Induced Hepatotoxicity and Protection (5 papers) and COVID-19 Clinical Research Studies (4 papers). The work is most often cited by research in Pharmacology (88 citations), Biochemistry (59 citations) and Biological Psychiatry (16 citations). Khaled Alhosaini has collaborated with scholars based in Saudi Arabia, India and China. Frequent co-authors include Othman A. Al‐Shabanah, Naif O. Al‐Harbi, Mohamed M. Hafez, Sheikh F. Ahmad, Mohamed M. Sayed‐Ahmed, Sabry M. Attia, Ahmed Nadeem, Hatem M. Abuohashish, Mohammed M. Ahmed and Mushtaq Ahmad Ansari. Their work appears in journals such as The FASEB Journal, International Journal of Molecular Sciences and Molecular Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.